OBJECTIVE: Membrane endothelial protein C receptor (mEPCR) is highly expressed in peritubular capillaries of kidneys from patients with active and poorly responsive lupus nephritis (LN). We investigated the hypothesis that changes in the microvasculature are widespread with extension to the dermal vasculature. METHODS: Skin biopsies from uninvolved skin (buttocks) were performed in 27 patients with LN and 5 healthy controls. Sections were stained with specific antibodies reactive with mEPCR, adiponectin, intercellular adhesion molecule-1 (ICAM-1), and CD31; then assessed by enumeration of stained blood vessels (percentage positive blood vessels) blinded to knowledge of clinical information. RESULTS: There was a significant increase in the prevalence of blood vessels that stained for mEPCR and ICAM-1 in patients compared to controls [94% vs 59% (p = 0.045) and 81% vs 67% (p = 0.037), respectively]. Adiponectin staining and CD31 staining were similar between the groups (45% vs 43% and 98% vs 92%). Dermal staining for mEPCR was greater in patients with proliferative glomerulonephritis than in those with membranous disease (96% vs 60%; p = 0.029). A composite of poor prognostic renal markers and death was significantly associated with greater expression of mEPCR staining. CONCLUSION: These data are consistent with the notion that in patients with LN, activation of the microvasculature extends beyond the clinically targeted organ. The insidious expression of this widespread vasculopathy may be a contributor to longterm comorbidities.
OBJECTIVE: Membrane endothelial protein C receptor (mEPCR) is highly expressed in peritubular capillaries of kidneys from patients with active and poorly responsive lupus nephritis (LN). We investigated the hypothesis that changes in the microvasculature are widespread with extension to the dermal vasculature. METHODS: Skin biopsies from uninvolved skin (buttocks) were performed in 27 patients with LN and 5 healthy controls. Sections were stained with specific antibodies reactive with mEPCR, adiponectin, intercellular adhesion molecule-1 (ICAM-1), and CD31; then assessed by enumeration of stained blood vessels (percentage positive blood vessels) blinded to knowledge of clinical information. RESULTS: There was a significant increase in the prevalence of blood vessels that stained for mEPCR and ICAM-1 in patients compared to controls [94% vs 59% (p = 0.045) and 81% vs 67% (p = 0.037), respectively]. Adiponectin staining and CD31 staining were similar between the groups (45% vs 43% and 98% vs 92%). Dermal staining for mEPCR was greater in patients with proliferative glomerulonephritis than in those with membranous disease (96% vs 60%; p = 0.029). A composite of poor prognostic renal markers and death was significantly associated with greater expression of mEPCR staining. CONCLUSION: These data are consistent with the notion that in patients with LN, activation of the microvasculature extends beyond the clinically targeted organ. The insidious expression of this widespread vasculopathy may be a contributor to longterm comorbidities.
Authors: N Ouchi; S Kihara; Y Arita; Y Okamoto; K Maeda; H Kuriyama; K Hotta; M Nishida; M Takahashi; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa Journal: Circulation Date: 2000-09-12 Impact factor: 29.690
Authors: Olga V Volpert; Tetiana Zaichuk; Wei Zhou; Frank Reiher; Thomas A Ferguson; P Michael Stuart; Mohammad Amin; Noel P Bouck Journal: Nat Med Date: 2002-04 Impact factor: 53.440
Authors: D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon Journal: Proc Natl Acad Sci U S A Date: 1996-09-17 Impact factor: 11.205
Authors: E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester Journal: Arthritis Rheum Date: 1982-11
Authors: Y Ishikawa; Y Akasaka; T Ishii; M Yoda-Murakami; N-H Choi-Miura; M Tomita; K Ito; L Zhang; Y Akishima; M Ishihara; M Muramatsu; M Taniyama Journal: Histopathology Date: 2003-01 Impact factor: 5.087
Authors: William D Shipman; Susan Chyou; Anusha Ramanathan; Peter M Izmirly; Sneh Sharma; Tania Pannellini; Dragos C Dasoveanu; Xiaoping Qing; Cynthia M Magro; Richard D Granstein; Michelle A Lowes; Eric G Pamer; Daniel H Kaplan; Jane E Salmon; Babak J Mehrara; James W Young; Robert M Clancy; Carl P Blobel; Theresa T Lu Journal: Sci Transl Med Date: 2018-08-15 Impact factor: 17.956
Authors: Evan Der; Saritha Ranabothu; Hemant Suryawanshi; Kemal M Akat; Robert Clancy; Pavel Morozov; Manjunath Kustagi; Mareike Czuppa; Peter Izmirly; H Michael Belmont; Tao Wang; Nicole Jordan; Nicole Bornkamp; Janet Nwaukoni; July Martinez; Beatrice Goilav; Jill P Buyon; Thomas Tuschl; Chaim Putterman Journal: JCI Insight Date: 2017-05-04
Authors: Paul Hoover; Evan Der; Celine C Berthier; Arnon Arazi; James A Lederer; Judith A James; Jill Buyon; Michelle Petri; H Michael Belmont; Peter Izmirly; David Wofsy; Nir Hacohen; Betty Diamond; Chaim Putterman; Anne Davidson Journal: Arthritis Care Res (Hoboken) Date: 2020-01-13 Impact factor: 4.794
Authors: Ji Hyun Sim; William G Ambler; Isabel F Sollohub; Mir J Howlader; Thomas M Li; Henry J Lee; Theresa T Lu Journal: J Immunol Date: 2021-01-15 Impact factor: 5.422